 CARLSBAD, Calif.--BUSINESS WIRE--Ra Medical Systems, Inc. NYSE American: RMED, a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports financial results for the three and 12 months ended December 31, 2020 and provides a business update. Recent Operational Highlights Enrolled 17 subjects in the companys atherectomy pivotal clinical trial since mid-November for a total of 30 subjects enrolled to date Completed in-house 